Trial of Program Budgetting and Marginal Analysis (PBMA) to assist cancer control planning in Australia

[1]  D. Whynes,et al.  Faecal occult blood screening for colorectal cancer: is it cost-effective? , 1998, Health economics.

[2]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[3]  A. Miller,et al.  Optimising the age, number of tests, and test interval for cervical screening in Canada. , 1982, Journal of epidemiology and community health.

[4]  M Johannesson,et al.  On the decision rules of cost-effectiveness analysis. , 1993, Journal of health economics.

[5]  S. Franceschi,et al.  "PAP" SMEAR AND THE RISK OF CERVICAL NEOPLASIA: QUANTITATIVE ESTIMATES FROM A CASE-CONTROL STUDY , 1984, The Lancet.

[6]  F. Olesen.  A case-control study of cervical cytology before diagnosis of cervical cancer in Denmark. , 1988, International journal of epidemiology.

[7]  D. Eddy,et al.  Screening for colorectal cancer , 1992, The Lancet.

[8]  D. Gyrd-Hansen,et al.  Colorectal cancer screening: efficiency and effectiveness. , 1998, Health economics.

[9]  J. Hiller,et al.  Screening for Colorectal Cancer: What are the Costs? , 1995, International Journal of Technology Assessment in Health Care.

[10]  Jonathan Roughgarden,et al.  Rule of thumb , 1991, Behavioral and Brain Sciences.

[11]  J. Donovan,et al.  Priority setting : the health care debate , 1996 .

[12]  P C Prorok,et al.  Evaluation of screening programmes for gynaecological cancer. , 1985, British Journal of Cancer.

[13]  J. Olsen,et al.  Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.

[14]  C. Mulrow,et al.  Colorectal cancer screening: clinical guidelines and rationale. , 1997, Gastroenterology.

[15]  D M Eddy,et al.  The frequency of cervical cancer screening. Comparison of a mathematical model with empirical data , 1987, Cancer.

[16]  E. A. Clarke,et al.  DOES SCREENING BY "PAP" SMEARS HELP PREVENT CERVICAL CANCER? A Case-control Study , 1979, The Lancet.

[17]  P. Correa,et al.  The impact of vaginal cytology on cervical cancer risks in cali, Colombia , 1984, International journal of cancer.

[18]  M. Gold.  Cost-effectiveness in health and medicine , 2016 .

[19]  R. Marks,et al.  Could a national skin cancer primary prevention campaign in Australia be worthwhile?: an economic perspective , 1999 .

[20]  Alan D. Lopez,et al.  The burden of disease and injury in Australia. , 2001, Bulletin of the World Health Organization.